Philippe Quittet

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Herve Ghesquieres, Daphné Krzisch, Emmanuelle Nicolas Virelizier, Salim Kanoun, Anne Claire Gac, Stéphanie Guidez, Mohamed Touati, Kamel Laribi, Judith Trotman, Christophe Bonnet, Agathe Waultier Rascalou, Frederique Orsini Piocelle, Marc Andre, Marguerite Fournier, Fabienne Morand, Alina Berriolo-Riedinger, Barbara Burroni, Diane Damotte, Alexandra Traverse-Glehen, Philippe Quittet, René-Olivier Casasnovas
Phase 2 LYSA study of prednisone, vinblastine, doxorubicin, bendamustine for untreated older Hodgkin lymphoma patients. Blood (2023)
Sylvain Lamure, François Van Laethem, Delphine De Verbizier, Claire Lozano, Eve Gehlkopf, Jean Jacques Tudesq, Chris Serrand, Mehdi Benzaoui, Tarik Kanouni, Adeline Quintard, John de Vos, Emmanuelle Tchernonog, Laura Platon, Xavier Ayrignac, Patrice Ceballos, Anne Sirvent, Mickael François, Hanane Guedon, Philippe Quittet, Cedric Mongellaz, Aurélie Conte, Charles Herbaux, Caroline Bret, Naomi Taylor, Valérie Dardalhon, Guillaume Cartron
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy. Cancers 13 (17) (2021)

Philippe Quittet.css-eqlu8i{font-size:small;padding-left:4px;}